QuidelOrtho Corporation reported second-quarter 2026 adjusted earnings of 13 cents per share, beating the Zacks Consensus Estimate by 425%, while revenue of $630.9 million surpassed estimates by 2.65%. However, the company lowered its full-year 2026 revenue guidance to $2.52-$2.60 billion from $2.70-$2.75 billion, citing persistent weakness in China and a softer respiratory testing outlook. Adjusted EBITDA guidance was cut to $540-$560 million from $615-$630 million, and adjusted earnings per share guidance was reduced to 65-90 cents from $1.80-$2.00. Shares fell around 25% in Friday's trading session following the reduced outlook.
Cardinal Health Inc
McKesson Corporation
Phibro Animal Health CorporationQuidel CorporationCompany slashed 2026 guidance, causing shares to plunge 25%.
